Purple Biotech Ltd
PPBT
$2.30
$0.0251.10%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.92M | 8.52M | 7.39M | 10.85M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 275.00K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 394.00K | 109.00K | 473.00K | 548.00K | |
| Total Current Assets | 6.31M | 8.91M | 7.86M | 11.40M | |
|
|
|||||
| Total Current Assets | 6.31M | 8.91M | 7.86M | 11.40M | |
| Net Property, Plant & Equipment | 223.00K | 288.00K | 359.00K | 417.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 27.84M | 27.84M | 27.84M | 28.04M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 34.38M | 37.04M | 36.07M | 39.86M | |
|
|
|||||
| Total Accounts Payable | 669.00K | 1.46M | 3.04M | 3.48M | |
| Total Accrued Expenses | 1.15M | 1.20M | 2.15M | 2.80M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 103.00K | 183.00K | 182.00K | 186.00K | |
| Total Finance Division Other Current Liabilities | 267.00K | 1.15M | 1.10M | 2.05M | |
| Total Other Current Liabilities | 267.00K | 1.15M | 1.10M | 2.05M | |
| Total Current Liabilities | 2.19M | 3.99M | 6.47M | 8.51M | |
|
|
|||||
| Total Current Liabilities | 2.19M | 3.99M | 6.47M | 8.51M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | 79.00K | 121.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 140.00K | 140.00K | 141.00K | 141.00K | |
| Total Liabilities | 2.33M | 4.13M | 6.69M | 8.77M | |
|
|
|||||
| Common Stock & APIC | 149.82M | 147.63M | 135.60M | 133.70M | |
| Retained Earnings | -146.23M | -144.69M | -143.62M | -141.22M | |
| Treasury Stock & Other | 28.41M | 29.92M | 37.34M | 38.54M | |
| Total Common Equity | 32.01M | 32.86M | 29.32M | 31.02M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 32.01M | 32.86M | 29.32M | 31.02M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | 44.00K | 51.00K | 61.00K | 71.00K | |
| Total Equity | 32.05M | 32.91M | 29.38M | 31.09M | |
|
|
|||||